About Stanford Dermatology
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Stanford Dermatology
During the past decade, Stanford Dermatology conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on
average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
An Expanded Access Program of Ruxolitinib for the Treatment of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplant
Approved for marketing
An Open-Label Study of Defibrotide for the Prevention of Acute Graft-versus-Host-Disease (AGvHD)
2018-02-21
2020-05-12
Completed
152
A Safety Trial of Lisocabtagene Maraleucel (JCAR017) for Relapsed and Refractory (R/R) B-cell Non-Hodgkin Lymphoma (NHL) in the Outpatient Setting (TRANSCEND-OUTREACH-007)
2018-11-29
2023-09-27
Active, not recruiting
41
Study of Alvocidib in Patients With Relapsed/Refractory AML Following Treatment With Venetoclax Combination Therapy
2020-01-15
2021-05-14
Terminated
11
Antigen-specific T Cell Therapy for AML or MDS Patients With Relapsed Disease After Allo-HCT
2020-02-20
2023-03-01
Unknown status
22
Antigen-specific T Cell Therapy for Patients With Relapsed Refractory Multiple Myeloma
2020-08-17
2023-12-31
Suspended
9
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Stanford Dermatology
According to Clinical.Site data, the most researched conditions in "Stanford Dermatology" are
"Rosacea" (2 trials), "Ageing" (1 trials), "Aging" (1 trials), "Intrinsic Aging of Skin" (1 trials) and "Lupus Erythematosus, Discoid" (1 trials). Many other conditions were trialed in "Stanford Dermatology" in a lesser frequency.
Clinical Trials Intervention Types at Stanford Dermatology
Most popular intervention types in "Stanford Dermatology" are "Drug" (4 trials), "Genetic" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "Diclofenac" (1 trials), "Metformin" (1 trials), "R932333" (1 trials) and "Retinol" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Stanford Dermatology
The vast majority of trials in "Stanford Dermatology" are
4 trials for "All" genders and 3 trials for "Female" genders.
Clinical Trials Status at Stanford Dermatology
Currently, there are NaN active trials in "Stanford Dermatology".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in Stanford Dermatology,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Stanford Dermatology, 2 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".